The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
Company | Cost to borrow (% year) | Shares available | Country |
---|---|---|---|
![]() Pfizer PFE | 0.2739% | 10 M | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 0.446% | 10 M | ๐บ๐ธ USA |
![]() Amgen AMGN | 0.25% | 3.1 M | ๐บ๐ธ USA |
![]() Biogen BIIB | 0.2735% | 4.4 M | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | 0.2547% | 10 M | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 0.25% | 10 M | ๐บ๐ธ USA |
![]() AstraZeneca AZN | 0.2581% | 10 M | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | 0.4081% | 4 M | ๐ฌ๐ง UK |
![]() Neurocrine Biosciences
NBIX | 0.4081% | 2.6 M | ๐บ๐ธ USA |